NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction
Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation
Benefit Of Chemotherapy Depends ER Status
WHI Update: No Increased Risk Of Cancer With Estrogen-Alone
Panitumumab Improves PFS In Metastatic Colon Cancer
NCI-Approved Trials Listed
Trending Stories
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Brown University reaches agreement with Trump administration to restore funding
- The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”